 |
Brentuximab vedotin |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-06 00:00:00 |
| Sponsor | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 |
Related Access Program
| |
Brentuximab vedotin |
|---|---|
| Trade Name | |
| Orphan Indication | Cutaneous T-cell lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2017-02-06 00:00:00 |
| Sponsor | Seattle Genetics, Inc.;21823 30th Drive Southeast;Bothell, Washington, 98021 |